Composition against osmotic stress

By using a combination of Rosela extract and betaine compounds on the skin, the problem of osmotic pressure disorder caused by osmotic stress is solved, and the synergistic protection effect against osmotic stress is achieved, reducing the cellular damage induced by stress factors is reduced and epidermal problems.

CN119031901APending Publication Date: 2024-11-26ELC MANAGEMENT LLC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202280092417.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2022-01-26
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The prior art is difficult to effectively combat skin epidermal osmotic pressure disorders caused by osmotic stress, such as fine lines, wrinkles, wrinkles, thinning, dry and dull appearance.

Method used

Using a composition containing Rosela extract and betaine compound, the synergistic protective properties are used to reduce stress-induced cellular damage and signs of epidermal osmotic pressure disorder by topical administration to the skin.

Benefits of technology

By combining betaine compounds and Roselona extracts in appropriate ratios and concentration ranges, synergistic protective properties against osmotic stress, reducing stress factor-induced cellular damage and signs of epidermal osmotic pressure disorder.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure GDA0005102195160000061
    Figure GDA0005102195160000061
  • Figure GDA0005102195160000121
    Figure GDA0005102195160000121
  • Figure GDA0005102195160000151
    Figure GDA0005102195160000151
Patent Text Reader

Abstract

The present invention relates to a composition, in particular a cosmetic and / or dermatological composition comprising a combination of a roselle extract and a betaine compound, and a non-therapeutic cosmetic treatment method of the skin to combat the signs of stress factor-induced epidermal osmolality disorders, such as fine lines and wrinkles of the skin, withered, thinned, dry, relaxed, dark appearance or appearance of heterogeneous surfaces.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of cosmetic or dermatological compositions. In particular, the present invention relates to a novel cosmetic and / or dermatological composition for topical application, comprising a Roselle extract and a betaine compound.

[0002] The invention also relates to the cosmetic use of said composition, and in particular to combating the signs of epidermal osmotic disturbances induced by stressors, such as the appearance of fine lines and wrinkles, withering, thinning, dryness, sagging, a dull appearance or a heterogeneous surface of the skin. Background Art

[0003] Skin is one of the most important organs of the human body. It exists in the outermost part of the body as a barrier to protect the human body from the adverse effects of the external environment. Keratinocytes at different stages of differentiation constitute the five-layer structure of the skin epidermis from the outside to the inside, such as the stratum corneum, the clear layer, the granular layer, the spinous layer and the basal layer. The epidermis composed of keratinocytes acts as a barrier function to inhibit the transmission of foreign bodies and prevent the loss of transepidermal water. However, with the development of modern society, due to continuous exposure to ultraviolet rays, air pollution, dry environment, chemicals, etc., skin cells are facing the continuous threat of osmotic stress. As an agent for protecting skin cells subjected to such stress, FR2877843 discloses the use of betaine in the field of cosmetics to combat skin aging and damage.

[0004] Furthermore, as a cosmetic composition for protecting the skin from different types of stress, US20100166814 provides a composition comprising a combination of at least two penetrants selected from the group consisting of taurine or a derivative thereof, inositol, betaine and trehalose.

[0005] Recently, it has been reported that the use of betaine in combination with various plant extracts can not only achieve moisturizing, but also achieve the additional beneficial effects brought by various plant extracts. For example, CN104523490 reports the use of betaine in combination with moisturizing plant extracts and whitening plant extracts to provide an exfoliating composition with whitening and moisturizing effects. In addition, US20160287658 reports that the combination of betaine and bamboo juice can significantly increase the water content in the stratum corneum. CN105411900 teaches that the combination of betaine and Leontopodium alpinum extract can enhance the effect of Leontopodium alpinum.

[0006] Hibiscus sabdariffa L. is a plant of the genus Hibiscus in the family Sphagaceae, and has value as a food raw material, natural pigment, and medical use. Due to its antioxidant properties and tyrosinase inhibitory effect, it is used in the anti-allergic composition in CN108653090. In addition, as described in CN104523490, a Hibiscus sabdariffa flower extract is mentioned as a whitening plant extract.

[0007] To the best of the inventors' knowledge, the synergistic protective properties of the combination of Roselle extract and betaine compounds against osmotic stress have never been disclosed. Summary of the invention

[0008] The inventors have conducted intensive studies to solve the problem of providing a combination which results in synergistic protective properties against osmotic stress.

[0009] As a result, the present inventors have discovered that by combining betaine compounds and Roselle extract in a specific manner, a synergistic protective property against osmotic stress can be produced.

[0010] In other words, in a first aspect, the present application provides a composition, especially a cosmetic and / or dermatological composition for topical application, comprising a Roselle extract and at least one betaine compound selected from the group consisting of betaine, its salts and analogs thereof.

[0011] In one embodiment of the present application, the betaine compound is glycine betaine.

[0012] In another embodiment of the present application, the Roselle extract is from the calyx or fruit of the Roselle.

[0013] In another embodiment of the present application, the Roselle extract is extracted by a water-based extraction method.

[0014] In a further embodiment of the present application, the betaine compound and the roselle extract are present in a weight ratio of 3:1 to 3:10, preferably 3:1 to 6:10 and more preferably 9:5 to 9:10.

[0015] In another embodiment of the present application, the betaine compound is present in an amount of 0.01 wt% to 0.2 wt%, preferably 0.03 wt% to 0.1 wt%, relative to the total weight of the composition.

[0016] In another embodiment of the present application, the Roselle extract is present in an amount of 0.01 to 0.1 wt %, preferably 0.02 to 0.1 wt %, and more preferably 0.05 to 0.1 wt %, relative to the total weight of the composition.

[0017] In a second aspect, the present application provides a non-therapeutic cosmetic treatment method comprising topically applying the above composition to a keratin material such as the skin.

[0018] In one embodiment of the present application, the above method is used to combat signs of stressor-induced epidermal osmotic imbalance, such as the appearance of fine lines and wrinkles, withering, thinning, dryness, sagging, dull appearance or heterogeneous surface of the skin.

[0019] In another embodiment of the present application, the stress factor is UV radiation, chemical and / or osmotic stress.

[0020] In a third aspect, the present application provides a cosmetic use of the above composition, which is used for caring for, protecting and / or making up the skin of the body or face, or for caring for hair.

[0021] In one embodiment of the present application, the above use is used to combat signs of stress factor-induced epidermal osmotic imbalance, such as the appearance of fine lines and wrinkles, withering, thinning, dryness, sagging, dull appearance or heterogeneous surface of the skin.

[0022] In another embodiment of the present application, the stress factor is UV radiation, chemical and / or osmotic stress.

[0023] The above composition, by comprising a combination of betaine compounds and roselle extract in an appropriate ratio and concentration range, can provide synergistic protective properties against osmotic stress, thereby reducing stress-induced cell damage and combating signs of epidermal osmotic imbalance induced by stress factors, such as the appearance of fine lines and wrinkles, withering, thinning, dryness, sagging, dull appearance or heterogeneous surface of the skin. DETAILED DESCRIPTION

[0024] I. Definitions

[0025] In the following, and unless otherwise indicated, the limits of a range of values ​​are included in the range, particularly in the expressions “between… and…” and “from… to…”.

[0026] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by those skilled in the art to which the invention belongs. When the definition of a term in this specification conflicts with the meaning commonly understood by those skilled in the art to which the invention belongs, the definition described herein will apply.

[0027] Throughout this application, the term "comprising" should be interpreted as covering all specifically mentioned features as well as optional, additional, unspecified features. As used herein, the use of the term "comprising" also discloses embodiments in which there are no features other than those specifically mentioned (i.e., "consisting of ...").

[0028] The term "skin cell" used herein refers to cells constituting the skin, including but not limited to keratinocytes, melanocytes, fibroblasts, T cells, and the like.

[0029] As used herein, the term "UV radiation" refers to ultraviolet radiation in the UVA and UVB wavelength ranges.

[0030] As used herein, the term "stress" refers to stress conditions to which skin cells may be exposed, such as ultraviolet light, air pollution, dry environments, chemicals, or osmotic stress. Osmotic stress here means a physiological dysfunction caused by a sudden change in the concentration of solutes surrounding a cell, which results in a rapid change in the movement of water across its cell membrane. Under hypertonic conditions - conditions where the supernatant contains a high concentration of salts, substrates, or any solutes - water is drawn out of the cell by osmosis.

[0031] As used herein, the term "synergistic protective properties" means that the protective effect produced by the combined use of two active ingredients, for example, at least one betaine compound (e.g., trimethylglycine) and the Roselle extract of the present invention (e.g., an extract from Roselle), is greater than the sum of the protective effects of the two active ingredients when used alone at the same dose.

[0032] Unless otherwise indicated, all numbers expressing quantities of ingredients, and so forth, used herein are to be understood as being modified by the term "about."

[0033] Unless otherwise indicated, all percentages mentioned herein are by weight, and all documents mentioned herein are incorporated by reference in their entirety.

[0034] II. Roselle Extract

[0035] The composition of the present invention comprises a roselle extract from roselle, which (also known as Rosella or Roselle) is a plant of the genus Hibiscus of the family Sphagaceae, having value as a food raw material, natural pigment and medical use. The extract from roselle provides improved skin texture, touch, hydration, moisturizing effect, and the appearance of fine lines and wrinkles, withering, thinning, dryness, sagging, dull appearance or heterogeneous surface of the skin or other undesirable skin conditions.

[0036] The Roselle extract used herein can be obtained from a plant part selected from the group consisting of flowers, seeds, leaves, fruits, calyx or roots of Roselle. Preferably, the Roselle extract used herein can be obtained from a plant part selected from the group consisting of flowers, calyx, fruits of Roselle. More preferably, the Roselle extract used herein can be obtained from the fruits of Roselle.

[0037] The Roselle extract used herein may be an aqueous or aqueous / alcoholic extract of the plant part. Preferably, the Roselle extract used herein may be extracted by an aqueous extraction method. Preferably, the Roselle extract used herein may be purchased from Lucas Meyer Cosmetics Company under the trade name Roselle extract, which is obtained by aqueous extraction and pH adjustment in the presence of an enzyme, followed by freeze drying. Roselle extract may also be commercially available as CAS No. 84775-96-2 or EC No. 283-920-7.

[0038] Relative to the total weight of the composition, the roselle extract used herein may be present in an amount of 0.01% to 0.1% by weight, preferably 0.02% to 0.1% by weight, more preferably 0.05% to 0.1% by weight. In one embodiment, relative to the total weight of the composition, the roselle extract contained in the composition may be present in an amount of 0.01%, 0.02%, 0.03%, 0.04%, 0.05%, 0.06%, 0.07%, 0.08%, 0.09%, 0.1% by weight.

[0039] Although not wishing to be bound by theory, it is believed that if the amount of the roselle extract is less than 0.01 wt % relative to the total weight of the composition, the roselle extract cannot exhibit a synergistic effect with the following betaine compounds because the amount is too low. However, if the amount is higher than 0.1 wt % relative to the total weight of the composition, it may have an adverse effect on skin cells due to cytotoxicity at a high concentration.

[0040] III. Betaine compounds

[0041] The composition of the present invention comprises at least one betaine compound selected from the group consisting of betaine, its salt and the like. The term "betaine" used herein means a general name of an intramolecular salt formed by a quaternary ammonium as a cation and an anion of an acid (specifically a carboxylic acid) in one molecule.

[0042] Betaine compounds suitable for use in the compositions of the present invention include those known for use in cosmetic or dermatological compositions.

[0043] In one embodiment, the betaine used herein may be selected from the group consisting of histidine betaine, glycine betaine, proline betaine, phenylalanine betaine, tyrosine betaine, tryptophan betaine, leucine betaine, isoleucine betaine, valine betaine, glutamic acid betaine, alanine betaine, aspartic acid betaine, lysine betaine and arginine betaine, depending on the amino acid involved.

[0044] In another embodiment, the betaine used herein can be selected from the group consisting of alkyl betaines, alkyl amido betaines, alkyl sulfonate betaines and imidazolinium betaines, specifically alkyl N-betaines, alkyl N-sulfonate betaines, acyl N-betaines, alkyl N-substituted aminopropionic acid, alkyl imidazolinium betaines and the like.

[0045] Additionally, betaine compounds suitable for use in the compositions of the present invention include salts and analogs of the betaines listed above.

[0046] In one embodiment, as the salt of betaine, the organic acid salt, inorganic acid salt or alkali salt of the above betaine can be used. Specifically, betaine hydrochloride, betaine hydrobromide, betaine hydroiodide, betaine chloroaurate, betaine hydrazide hydrochloride, etc. can be used.

[0047] In a preferred embodiment, the betaine used herein may be glycine betaine, which is also known as trimethylglycine, having the following structure.

[0048]

[0049] In a preferred embodiment, the betaine used herein may be glycine betaine, which is commercially available as CAS No. 107-43-7.

[0050] Furthermore, the term "analog" as used herein refers to any compound having similar properties to betaine, specifically trimethylglycine.

[0051] Relative to the total weight of the composition, the betaine compound used herein may be present in an amount of 0.01% to 0.2% by weight, preferably 0.03% to 0.1% by weight. In one embodiment, the betaine compound contained in the composition of the present invention may be present in an amount of 0.01%, 0.02%, 0.03%, 0.04%, 0.05%, 0.06%, 0.07%, 0.08%, 0.09%, 0.1% or 0.2% by weight, relative to the total weight of the composition.

[0052] Although not wishing to be bound by theory, it is believed that if the amount of the betaine compound is less than 0.01 wt % relative to the total weight of the composition, the betaine compound cannot exhibit a synergistic effect with the roselle extract because the amount is too low. However, if the amount is higher than 0.1 wt % relative to the total weight of the composition, the synergistic effect will not be increased, and thus it is not preferred from a cost perspective.

[0053] The composition of the present invention comprises a roselle extract and at least one betaine compound as defined above. In one embodiment, the weight ratio of the betaine compound to the roselle extract is 3:1 to 3:10, preferably 3:1 to 6:10, more preferably 9:5 to 9:10.

[0054] IV. Other ingredients

[0055] The composition of the present invention may be in solid, semi-solid or liquid form and may be in solution, emulsion, suspension or anhydrous form. If in solution or suspension form, the composition may contain about 1%-99.9%, preferably about 5%-95%, more preferably about 10%-90% water. If in emulsion form, the composition may contain about 1%-99%, preferably about 5%-90%, more preferably about 10%-85% water and about 1-99%, preferably about 5%-90%, more preferably about 5%-75% oil. If in anhydrous form, the composition may contain about 10%-99% oil and 10%-99% curing agent.

[0056] The compositions of the present invention may contain other ingredients, including but not limited to those described herein, as long as the synergistic protective effect of the compositions of the present invention is not affected.

[0057] A. Moisturizer

[0058] The compositions of the present invention may contain one or more humectants. If present, it may range from about 0.1 to 75%, preferably from about 0.5 to 70%, more preferably from about 0.5 to 40%. Examples of suitable humectants include ethylene glycol, sugars, and the like. Suitable glycols are in monomeric or polymeric form and include polyethylene glycol and polypropylene glycol, such as PEG 4-10, which is a polyethylene glycol having 4 to 10 repeating ethylene oxide units; and C 1-6 Alkylene glycols, such as propylene glycol, butylene glycol, pentylene glycol, etc. Suitable sugars, some of which are also polyols, are also suitable humectants. Examples of such sugars include glucose, fructose, honey, hydrogenated honey, inositol, maltose, mannitol, maltitol, sorbitol, sucrose, xylitol, xylose, etc. Also suitable is urea. Preferably, the humectant used in the composition of the present invention is C 1-6 , preferably C 2-4 Alkylene glycol, most particularly butanediol.

[0059] B. Plant extracts

[0060] In addition to the roselle extract, the composition of the present invention may contain one or more additional plant extracts. The currently recommended range is about 0.0001% to 20%, preferably about 0.0005% to 15%, and more preferably about 0.001% to 10%. Suitable plant extracts include extracts from plants (herbs, roots, flowers, fruits, seeds) such as flowers, fruits, vegetables, etc., including yeast fermentation extracts, Padina pavonica extracts, Thermus thermophilis fermentation extracts, Camelina satuva seed oil, Boswellia serrata extract, olive extract, Acacia dealbata extract, Acer serrata extract, saccharinum) (sugar maple), Acidopholus, Acorus, Aesculus, Agaricus, Agave, Agrimonia, algae, aloe, citrus, Brassica, cinnamon, orange, apple, blueberry, cranberry, peach, pear, lemon, lime, pea, seaweed, caffeine, green tea, chamomile, willow bark, mulberry, and those listed in the CTFA Cosmetic Ingredient Handbook, Eighth Edition, Volume 2, pages 1646 to 1660.Additional specific examples include, but are not limited to, Glycyrrhiza glabra, Salix nigra, Macrocycstis pyrifera, Pyrus malus, Saxifraga sarmentosa, Vitis vinifera, Morus nigra, Scutellaria baicalensis, Anthemis nobilis, Salvia sclarea, Rosmarinus officianalis, Citrus limonum, Panax ginseng, Siegesbeckia orientalis, Fructus mume, Ascophyllum nodosum, Glycime soja extract, Beta vulgaris, Haberlea rhodopensis, Polygonum cuspidatum. cuspidatum), sweet orange (Citrus aurantiumdulcis), grape (Vitis vinifera), Selaginella (Selaginella tamariscina), hops (Humulus lupulus), citrus peel extract (Citrus reticulata Peel), pomegranate (Punica granatum), Asparagus (Asparagopsis), turmeric (Curcuma longa), Menyanthes trifoliata, sunflower (Helianthus annuus), barley (Hordeum vulgare), cucumber (Cucumis sativus), oak moss (Evernia prunastri), tree moss (Evernia furfuracea), Sudan kola nut (kola acuminata), and mixtures thereof.

[0061] C. Surfactant

[0062] The compositions of the present invention may contain one or more surfactants, especially if in the form of an emulsion. However, such surfactants may also be used if the composition is a solution, suspension or anhydrous. If present, the surfactant may range from about 0.001 to 30%, preferably from about 0.005 to 25%, more preferably from about 0.1 to 20% by weight of the total composition. Suitable surfactants may be silicone or organic, nonionic, anionic, amphoteric or zwitterionic.

[0063] 1. Organic nonionic surfactant

[0064] The compositions of the present invention may contain one or more nonionic organic surfactants. Suitable nonionic surfactants include alkoxylated alcohols or ethers formed by reacting an alcohol with an alkylene oxide, typically ethylene oxide or propylene oxide. Suitable alcohols include mono-, di- or polyhydroxy short chain (C 1-6 ) alcohol; Aromatic or aliphatic saturated or unsaturated fats (C 12-40 ) alcohol; etc.

[0065] Cholesterol is suitable, or an aromatic or aliphatic saturated or unsaturated fatty alcohol, which may have 6 to 40, preferably about 1 to 30, more preferably about 12 to 22 carbon atoms. Examples include oleyl alcohol, cetearyl alcohol, cetyl acetate, stearyl alcohol, isostearyl alcohol, behenyl alcohol, and the like. Examples of such ingredients include oleth 2-100; steareth 2-100; beheneth 5-30; ceteareth 2-100; ceteth 2-100; ceteth 2-100; choleth 2-100, wherein the numerical range refers to the number of repeating ethylene oxide units, for example ceteth 2-100 means a ceteth wherein the number of repeating ethylene oxide units is in the range of 2 to 100. Derivatives of alkoxylated alcohols are also suitable, such as phosphates thereof.

[0066] Some preferred organic nonionic surfactants include oleth-3, oleth h-5, oleth-3 phosphate, choleth-24; cetherth-24; and the like.

[0067] Also suitable are alkoxylated alcohols formed from mono-, di- or polyhydric short chain alcohols, such as those having from about 1 to 6 carbon atoms. Examples include glucose, glycerol or their alkylated derivatives. Examples include glycereth 2-100; gluceth 2-100; methyl gluceth 2-100, and the like. More preferred are methyl gluceth-20; glycereth-26, and the like.

[0068] Other types of alkoxylated alcohols are suitable surfactants, including ethylene oxide polymers with varying numbers of repeating EO groups, commonly referred to as PEG 12-200. More preferred is PEG-75, which is available from Dow Chemical under the tradename polyethylene glycol PEG-3350.

[0069] Other suitable nonionic surfactants include alkoxylated sorbitan and alkoxylated sorbitan derivatives. For example, alkoxylation, specifically ethoxylation, of sorbitan provides polyalkoxylated sorbitan derivatives. Esterification of polyalkoxylated sorbitan provides sorbitan esters, such as polysorbate. For example, polyalkoxylated sorbitan can be prepared using C 6-30 , preferably C 12-22 Fatty acid esterification. Examples of such ingredients include polysorbate 20-85, sorbitan oleate, sorbitan sesquioleate, sorbitan palmitate, sorbitan sesquiisostearate, sorbitan stearate, and the like.

[0070] 2. Siloxane or silane surfactant

[0071] Also suitable are the various types of silicone or silane-based surfactants. Examples include organosilicones substituted with ethylene oxide or propylene oxide groups, such as PEG dimethicone, which is a dimethicone substituted with polyethylene glycol, including those dimethicone having the INCI name PEG-1 dimethicone; PEG-4 dimethicone; PEG-8 dimethicone; PEG-12 dimethicone; PEG-20 dimethicone; etc.

[0072] Also suitable are silanes substituted with ethoxy or propoxy groups or both, such as various types of PEG methyl ether silanes, such as bis-PEG-18 methyl ether dimethyl silane; and the like.

[0073] Other examples of silicone-based surfactants include those having the common names dimethicone copolyol; cetyl dimethicone copolyol; and the like.

[0074] D. Biomaterials

[0075] The compositions of the present invention may contain various types of biological materials, such as those derived from cells, fermented materials, etc. If present, such materials may range from about 0.001% to 30%, preferably from about 0.005% to 25%, more preferably from about 0.01% to 20%. Examples include fragments of cellular RNA or DNA, or probiotic microorganisms. Particularly preferred are RNA fragments.

[0076] E. Thickener

[0077] Suitable thickeners may be incorporated into the compositions of the present invention. If present, a suggested range is from about 0.01% to 30%, preferably from about 0.1% to 20%, more preferably from about 0.5% to 15% by weight of the total composition.

[0078] Examples of thickeners include animal wax, vegetable wax, mineral wax, silicone wax or synthetic wax, which may have a melting point in the range of about 30°C to 150°C, including but not limited to waxes prepared by Fischer-Tropsch synthesis, such as polyethylene or synthetic wax; or various plant waxes, such as bayberry wax, candelilla wax, ozokerite, gum arabic, beeswax, ceresin, cetyl acetate, flower wax, citrus wax, carnauba wax, Jojoba wax, Japan wax, polyethylene, microcrystalline, rice bran, lanolin wax, mink wax, montan wax, bayberry wax, small crown coconut wax, ozokerite, palm kernel wax, paraffin, avocado wax, apple wax, shellac wax, sage wax, wine lees wax, grape wax and their polyalkylene glycol derivatives, such as PEG6-20 beeswax or PEG-12 carnauba wax; or fatty acids or fatty alcohols, including esters thereof, such as hydroxystearic acid (e.g. 12-hydroxystearic acid), tristearin, methyl behenate, etc.

[0079] Silica, silicates, silica silylate and their alkali metal or alkaline earth metal derivatives are also suitable as thickeners. These silicas and silicates are usually found in particulate form and include silicon dioxide, silica silylate, magnesium aluminum silicate and the like.

[0080] Silicone elastomers can also be used as thickeners. Such elastomers include those formed by curing by addition reaction by reaction of SiH-containing diorganosiloxane and organopolysiloxane or α-ω diene with terminal olefinic unsaturation in the presence of platinum metal catalyst. Such elastomers can also be formed by other reaction methods, such as condensation curing organopolysiloxane composition via dehydrogenation reaction between hydroxyl-terminated diorganopolysiloxane and SiH-containing diorganopolysiloxane or αω diene in the presence of organotin compound; or by condensation curing organopolysiloxane composition using condensation reaction between hydroxyl-terminated diorganopolysiloxane and hydrolyzable organosiloxane in the presence of organotin compound or titanate; peroxide-cured organopolysiloxane composition cured by heat in the presence of organic peroxide catalyst.

[0081] One type of potentially suitable elastomer is prepared by addition reaction curing an organopolysiloxane or α-ω diene having at least 2 lower alkenyl groups per molecule; and an organopolysiloxane having at least 2 silicon-bonded hydrogen atoms per molecule; and a platinum catalyst. Although lower alkenyl groups, such as vinyl groups, may be present at any position in the molecule, terminal ethylenic unsaturation at one or both molecular ends is preferred. The molecular structure of this component may be linear, branched linear, cyclic or network. Examples of these organopolysiloxanes are exemplified by methylvinylsiloxane, methylvinylsiloxane-dimethylsiloxane copolymers, dimethylvinylsiloxy-terminated dimethylpolysiloxane, dimethylvinylsiloxy-terminated dimethylsiloxane-methylphenylsiloxane copolymers, dimethylvinylsiloxy-terminated dimethylsiloxane-methylvinylsiloxane copolymers, trimethylsiloxy-terminated dimethylsiloxane-methylvinylsiloxane copolymers, trimethylsiloxy-terminated dimethylsiloxane-methylphenylsiloxane-methylvinylsiloxane copolymers, dimethylvinylsiloxy-terminated methyl(3,3,3-trifluoropropyl)polysiloxane and dimethylvinylsiloxy-terminated dimethylsiloxane-methyl(3,3,-trifluoropropyl)siloxane copolymers, decadiene, octadiene, heptadiene, hexadiene, pentadiene or tetradiene or triene.

[0082] Curing occurs via an addition reaction of the silicon-bonded hydrogen atoms in dimethylmethylhydrogensiloxane with siloxane or α-ω diene using a catalyst as described herein. In order to form a highly crosslinked structure, the methylhydrogensiloxane must contain at least 2 silicon-bonded hydrogen atoms per molecule to optimize its function as a crosslinker.

[0083] Catalysts used in the addition reaction of silicon-bonded hydrogen atoms and alkenyl groups, and specifically exemplified by chloroplatinic acid, possibly dissolved in an alcohol or ketone and the solution optionally aged, chloroplatinic acid-olefin complexes, chloroplatinic acid-alkenylsiloxane complexes, chloroplatinic acid-diketone complexes, platinum black and supported platinum.

[0084] Examples of suitable silicone elastomers for use in the compositions of the present invention may be in powder form, or dispersed or dissolved in a solvent, such as a volatile or non-volatile silicone, or a silicone compatible carrier, such as an alkane or ester. Examples of silicone elastomer powders include vinyl dimethicone / methicone silsesquioxane crosspolymers, such as Shin-Etsu's KSP-100, KSP-101, KSP-102, KSP-103, KSP-104, KSP-105, hybrid silicone powders containing fluoroalkyl groups, such as Shin-Etsu's KSP-200, which is a fluorosilicone elastomer, and hybrid silicone powders containing phenyl groups, such as Shin-Etsu's KSP-300, which is a phenyl substituted silicone elastomer; and Dow Corning's DC 9506. Examples of silicone elastomer powders dispersed in a silicone compatible carrier include dimethicone / vinyl dimethicone crosspolymers supplied by various suppliers, including Dow Corning Corporation, trade names 9040 or 9041, GE Silicones, trade name SFE 839, or Shin-Etsu Silicones, trade names KSG-15, 16, 18. The CTFA name of KSG-15 is cyclopentasiloxane / dimethicone / vinyl dimethicone crosspolymer. The INCI name of KSG-18 is phenyl trimethicone / dimethicone / phenyl vinyl dimethicone crosspolymer. Silicone elastomers can also be purchased from Grant Industries under the trademark Gransil. Also suitable are silicone elastomers having long chain alkyl substitutions, such as lauryl dimethicone / vinyl dimethicone crosspolymers supplied by Shin Etsu under the trade names KSG-31, KSG-32, KSG-41, KSG-42, KSG-43, and KSG-44. Crosslinked organopolysiloxane elastomers useful in the present invention and methods of making them are further described in U.S. Pat. No. 4,970,252, issued to Sakuta et al. on Nov. 13, 1990; U.S. Pat. No. 5,760,116, issued to Kilgour et al. on Jun. 2, 1998; U.S. Pat. No. 5,654,362, issued to Schulz, Jr. et al. on Aug. 5, 1997; and Japanese Patent Application JP 61-18708 assigned to PolaKasei Kogyo KK, each of which is incorporated by reference in its entirety.

[0085] Polysaccharides can be suitable aqueous phase thickeners. Examples of such polysaccharides include materials of natural origin, such as agar, agarose, alcaligenes polysaccharide, algin, alginic acid, gum arabic, pullulan, chitin, dextran, cassia gum, cellulose gum, gelatin, gellan gum, hyaluronic acid, hydroxyethyl cellulose, methyl cellulose, ethyl cellulose, pectin, sclerotium gum, xanthan gum, pectin, trehalose, gelatin, etc.

[0086] Also suitable are different types of synthetic polymer thickeners. One type includes acrylic polymer thickeners composed of monomers A and B, wherein A is selected from the group consisting of acrylic acid, methacrylic acid, and mixtures thereof; and B is selected from the group consisting of C1-22 alkyl acrylates, C1-22 alkyl methacrylates, and mixtures thereof. Acrylic polymer solutions include those sold by Seppic, Inc. under the trade name Solutions or those sold under the trade name Those solutions that are sold.

[0087] Also suitable are acrylic polymer thickeners which are copolymers of A, B and C monomers, wherein A and B are as defined above, and C has the general formula:

[0088]

[0089] Where Z is -(CH2) m ; wherein m is 1-10, n is 2-3, o is 2-200, and R is C 10-30 Straight or branched chain alkyl. Examples of the above second thickeners are copolymers, wherein A and B are as defined above, and C is CO, and wherein n, o and R are as defined above. Examples of such second thickeners include acrylates / steareth-20 methacrylate copolymers, sold by Rohm & Haas under the trade name Acrysol ICS-1.

[0090] Likewise suitable are acrylate-based anionic amphiphilic polymers containing at least one hydrophilic unit and at least one allyl ether unit containing a fatty chain. Preferred are those in which the hydrophilic unit contains an ethylenically unsaturated anionic monomer, more particularly a vinyl carboxylic acid, such as acrylic acid, methacrylic acid or a mixture thereof, and in which the allyl ether unit containing a fatty chain corresponds to a monomer of the formula:

[0091] CH2=CR′CH2OB n R

[0092] wherein R′ represents H or CH 3 , B represents an ethyleneoxy group, n is 0 or an integer from 1 to 100, R represents a hydrocarbon group selected from alkyl, arylalkyl, aryl, alkylaryl and cycloalkyl groups, containing 8 to 30 carbon atoms, preferably 10 to 24, and even more particularly 12 to 18 carbon atoms. More preferred in this case is wherein R′ represents H, n is equal to 10, and R represents a stearyl (C 18 ). Anionic amphiphilic polymers of this type are described and prepared in U.S. Pat. Nos. 4,677,152 and 4,702,844, both of which are hereby incorporated by reference in their entirety. Among these anionic amphiphilic polymers, polymers formed from 20 to 60 wt % of acrylic acid and / or methacrylic acid, 5 to 60 wt % of lower alkyl methacrylate, 2 to 50 wt % of allyl ether containing a fatty chain as described above, and 0 to 1 wt % of a crosslinking agent, which is a well-known copolymerizable multiethylenically unsaturated monomer, such as diallyl phthalate, allyl (meth)acrylate, divinylbenzene, (poly)ethylene glycol dimethacrylate, and methylenebisacrylamide. A commercial example of such a polymer is a crosslinked terpolymer of methacrylic acid, ethyl acrylate, polyethylene glycol (with 10 EO units) stearyl ether or steareth-10, in particular those sold under the names SALCARE SC80 and SALCARE SC90 by the company Allied Colloids, which are aqueous emulsions containing 30% of a crosslinked terpolymer of methacrylic acid, ethyl acrylate and steareth-10 allyl ether (40 / 50 / 10).

[0093] Also suitable are acrylate copolymers, such as Polyacrylate-3, which is a copolymer of methacrylic acid, methyl methacrylate, methylstyrene isopropyl isocyanate, and PEG-40 behenate monomers; Polyacrylate-10, which is a copolymer of sodium acryloyldimethyltaurate, sodium acrylate, acrylamide, and vinylpyrrolidone monomers; or Polyacrylate-11, which is a copolymer of sodium acryloyldimethacryloyldimethyltaurate, sodium acrylate, hydroxyethyl acrylate, lauryl acrylate, butyl acrylate, and acrylamide monomers.

[0094] Also suitable are crosslinked acrylate-based polymers, in which one or more of the acrylic acid groups may have a substituted long chain alkyl group (such as 6-40, 10-30, etc.), for example acrylates / C10-30 alkyl acrylate crosspolymers, which are copolymers of C10-30 alkyl acrylates and one or more of acrylic acid, methacrylic acid or one of their simple esters crosslinked with an allyl ether of sucrose or an allyl ether of pentaerythritol. Such polymers are commonly sold under the trade names of Carbopol or Pemulen and have the CTFA name Carbomer.

[0095] One particularly suitable type of aqueous phase thickener is an acrylate-based polymer thickener sold by Clariant under the Aristoflex trademark, such as Aristoflex AVC, which is ammonium acryloyldimethyltaurate / VP copolymer; Aristoflex AVL, which is the same polymer found in AVC dispersed in a mixture containing caprylic / capric triglyceride, trilaureth-4, and polyglyceryl-2 sesquiisostearate; or Aristoflex HMB, which is ammonium acryloyldimethyltaurate / beheneth-25 methacrylate crosspolymer, and the like.

[0096] Various polyethylene glycol (PEG) derivatives with a degree of polymerization ranging from 1,000 to 200,000 are also suitable as thickeners. Such ingredients are represented by the name "PEG" followed by the degree of polymerization in thousands, such as PEG-45M, which means that the PEG has 45,000 repeating ethylene oxide units. Examples of suitable PEG derivatives include PEG 2M, 5M, 7M, 9M, 14M, 20M, 23M, 25M, 45M, 65M, 90M, 115M, 160M, 180M, etc.

[0097] Also suitable are polyglycerols as repeating glycerol moieties, wherein the number of repeating moieties ranges from 15 to 200, preferably from about 20 to 100. Examples of suitable polyglycerols include those having the CTFA designations polyglycerol-20, polyglycerol-40, and the like.

[0098] F. Oil

[0099] In the case where the composition of the present invention is in the form of an emulsion, the composition will contain an oil phase. Oily ingredients are desirable for skin moisturizing and protective properties. Suitable oils include silicones, esters, vegetable oils, synthetic oils, including but not limited to those described herein. The oil may be volatile or non-volatile, and is preferably in a pourable liquid form at room temperature. The term "volatile" means that the oil has a measurable vapor pressure, or a vapor pressure of at least about 2 mm of mercury at 20°C. The term "non-volatile" means that at 20°C, the oil has a vapor pressure of less than about 2 mm of mercury.

[0100] 1. Volatile Oil

[0101] Suitable volatile oils generally have viscosities ranging from about 0.5 centistokes to 5 centistokes at 25°C and include linear siloxanes, cyclic siloxanes, paraffins, or mixtures thereof.

[0102] (a) Volatile siloxane

[0103] Cyclic siloxanes are a type of volatile siloxane that can be used in the composition. Such siloxanes have the general formula:

[0104]

[0105] wherein n=3-6, preferably 4, 5 or 6.

[0106] Also suitable are linear volatile siloxanes, such as those having the general formula:

[0107] (CH3)3Si-O-[Si(CH3)2-O] n -Si(CH3)3

[0108] wherein n=0, 1, 2, 3, 4 or 5, preferably 0, 1, 2, 3 or 4.

[0109] Cyclic siloxanes and linear volatile siloxanes are available from a variety of commercial sources, including Dow Corning Corporation and General Electric. Dow Corning linear volatile siloxanes are sold under the trade names Dow Corning 244, 245, 344 and 200 fluids. These fluids include hexamethyldisiloxane (viscosity 0.65 centistokes (abbreviated as cst)), octamethyltrisiloxane (1.0 centistokes), decamethyltetrasiloxane (1.5 centistokes), dodecamethylpentasiloxane (2 centistokes) and mixtures thereof, all viscosity measurements being made at 25°C.

[0110] Suitable branched chain volatile silicones include alkyl trimethylsiloxanes, such as methyl trimethylsiloxane, branched chain volatile silicones having the general formula:

[0111]

[0112] Methyl trimethicone is commercially available from Shin-Etsu Silicones under the trade name TMF-1.5 and has a viscosity of 1.5 centistokes at 25°C.

[0113] (b) Volatile alkanes

[0114] Various straight or branched chain alkanes having 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20 carbon atoms, more preferably 8 to 16 carbon atoms, are also suitable as volatile oils. Suitable hydrocarbons include pentane, hexane, heptane, decane, dodecane, tetradecane, tridecane and C 8-20 Isoparaffins, as disclosed in U.S. Pat. Nos. 3,439,088 and 3,818,105, both of which are hereby incorporated by reference.

[0115] Preferred volatile paraffins have a molecular weight of 70-225, preferably 160 to 190, and have a boiling point range of 30 to 320, preferably 60 to 260°C, and a viscosity of less than about 10 cst at 25°C. Such paraffins are available from EXXON under the ISOPARS trademark and from Permethyl Corporation. Suitable C 12 Isoparaffins are manufactured by Permethyl Corporation under the trade name Permethyl 99A. Various commercially available C 16 Isoparaffins, such as isohexadecane (trade name Permethyl R), are also suitable.

[0116] 2. Non-volatile oil

[0117] A variety of non-volatile oils are also suitable for use in the compositions of the present invention. Non-volatile oils generally have a viscosity of greater than about 5 centistokes to 10 centistokes at 25°C, and may have a viscosity in the range of up to about 1,000,000 centipoise at 25°C. Examples of non-volatile oils include, but are not limited to:

[0118] (a) Esters

[0119] Suitable esters are monoesters, diesters and triesters.The composition may comprise one or more esters selected from the following group or mixtures thereof.

[0120] (i) Monoester

[0121] Monoesters are defined as esters formed by the reaction of monocarboxylic acids with the formula R-COOH, wherein R is a straight or branched saturated or unsaturated alkyl group having 2 to 45 carbon atoms, or a phenyl group; and alcohols with the formula R-OH, wherein R is a straight or branched saturated or unsaturated alkyl group having 2 to 30 carbon atoms, or a phenyl group. Both the alcohol and the acid may be substituted with one or more hydroxyl groups. One or both of the acid or alcohol may be a "fatty" acid or alcohol, and may have about 6 to 30 carbon atoms, more preferably 12, 14, 16, 18 or 22 carbon atoms, in a straight or branched, saturated or unsaturated form. Examples of monoester oils that can be used in the compositions of the present invention include hexyl laurate, butyl isostearate, hexadecyl isostearate, hexadecyl palmitate, isostearyl neopentanoate, stearyl heptanoate, isostearyl isononanoate, stearyl lactate, stearyl octanoate, stearyl stearate, isononyl isononanoate, etc.

[0122] (ii) Diesters

[0123] Suitable diesters are the reaction products of dicarboxylic acids and aliphatic or aromatic alcohols or aliphatic or aromatic alcohols with at least two substituted hydroxyl groups and monocarboxylic acids. The dicarboxylic acids may contain 2 to 30 carbon atoms and may be in straight or branched, saturated or unsaturated form. The dicarboxylic acids may be substituted by one or more hydroxyl groups. The aliphatic or aromatic alcohols may also contain 2 to 30 carbon atoms and may be in straight or branched, saturated or unsaturated form. Preferably, one or more of the acid or alcohol is a fatty acid or alcohol, i.e. containing 12-22 carbon atoms. The dicarboxylic acid may also be an alpha hydroxy acid. The ester may be in the form of a dimer or trimer. Examples of diester oils useful in the compositions of the present invention include diisostearyl malate, neopentyl glycol dicaprylate, dibutyl sebacate, dicetyl dimer dimer linoleate, dicetyl adipate, diisocetyl adipate, diisononyl adipate, diisostearyl dimer linoleate, diisostearyl dimer linoleate, diisostearyl malate, dioctyl malate, and the like.

[0124] (iii) Triesters

[0125] Suitable triesters include the reaction products of tricarboxylic acids and aliphatic or aromatic alcohols, or the reaction products of aliphatic or aromatic alcohols having three or more substituted hydroxyl groups and monocarboxylic acids. As with the monoesters and diesters described above, the acids and alcohols contain 2 to 30 carbon atoms and may be saturated or unsaturated, straight chain or branched, and may be substituted with one or more hydroxyl groups. Preferably, one or more of the acid or alcohol is a fatty acid or alcohol containing 12 to 22 carbon atoms. Examples of triesters include esters of arachidonic acid, citric acid or behenic acid, such as triarachidonic acid, tributyl citrate, triisostearyl citrate, tri-C citrate, and tri-C 2-hydroxy-1- ... 12-13Alkyl esters, tricaprylin, trioctyl citrate, tridecyl behenate, trioctyl dodecanol citrate, tridecyl behenate; or tridecyl coconut oil, tridecyl isononanoate, etc.

[0126] Esters suitable for use in the compositions of the present invention are further described in the CTFA Cosmetic Ingredient Dictionary and Handbook, 11th Edition, 2006, under the category of "Esters", the text of which is hereby incorporated by reference in its entirety.

[0127] (b) Hydrocarbon oil

[0128] It may be desirable to incorporate one or more non-volatile hydrocarbon oils into the compositions of the present invention. Suitable non-volatile hydrocarbon oils include paraffins and olefins, preferably those having greater than about 20 carbon atoms. Examples of such hydrocarbon oils include C 24-28 Olefins, C 30-45 Olefins, C 20-40 Isoparaffins, hydrogenated polyisobutene, polyisobutene, polydecene, hydrogenated polydecene, mineral oil, pentahydrosqualene, squalene, squalane, and mixtures thereof. In a preferred embodiment, such hydrocarbons have a molecular weight in the range of about 300 Daltons to 1000 Daltons.

[0129] (c) Fatty acid glycerides

[0130] Synthetic or naturally occurring fatty acid glycerides or triglycerides are also suitable for use in the compositions. Both vegetable and animal sources may be used. Examples of such oils include castor oil, lanolin oil, C 10-18 Triglycerides, caprylic / capric / triglycerides, sweet almond oil, almond oil, sesame oil, camelina oil, tamanu oil, coconut oil, corn oil, cottonseed oil, linseed oil, ink oil, olive oil, palm oil, ice grass fat, rapeseed oil, soybean oil, grape seed oil, sunflower seed oil, walnut oil, etc.

[0131] Also suitable are synthetic or semi-synthetic glycerides, such as fatty acid mono-, di- and triglycerides, which are natural fats or oils that have been modified, for example mono-, di- or triesters of polyols such as glycerol. 12-22 ) carboxylic acid with one or more repeating glyceryl, glyceryl stearate, diglyceryl diisostearate, polyglyceryl-3 isostearate, polyglyceryl-4 isostearate, polyglyceryl-6 ricinoleate, glyceryl dioleate, glyceryl diisostearate, glyceryl tetraisostearate, glyceryl tricaprylate, diglyceryl distearate, glyceryl linoleate, glyceryl myristate, glyceryl isostearate, PEG castor oil, PEG glyceryl oleate, PEG glyceryl stearate, PEG glyceryl tallowate, etc.

[0132] (d) Non-volatile siloxane

[0133] Non-volatile silicone oils, both water soluble and water insoluble, are also suitable for use in the composition. Such silicones preferably have a viscosity of about greater than 5 cst to 800,000 cst, preferably 20 cst to 200,000 cst at 25° C. Suitable water insoluble silicones include amine functional silicones, such as amodimethicone.

[0134] For example, such non-volatile siloxanes may have the following general formula:

[0135]

[0136] Where R and R' are each independently C 1-30 wherein A is a methylsiloxy end-capping unit; in particular, trimethylsiloxy and R and R′ are each independently C 1-30 A straight chain or branched alkyl, phenyl or trimethylsilyloxy group, more preferably C 1-22 alkyl, phenyl or trimethylsiloxy, most preferably methyl, phenyl or trimethylsiloxy, and the resulting siloxane is polydimethylsiloxane, phenyl polydimethylsiloxane, diphenyl polydimethylsiloxane, phenyl polytrimethylsiloxane or trimethylsiloxyphenyl polydimethylsiloxane. Other examples include alkyl polydimethylsiloxanes such as hexadecyl polydimethylsiloxane, wherein at least one R is a fatty alkyl (C 12 , C 14 , C 16 , C 18 , C 20 or C 22 ), and the other R is methyl, and A is a trimethylsiloxy end-capping unit, provided that such alkyl polydimethylsiloxane is a pourable liquid at room temperature. Phenyl trimethicone is available from Dow Corning Corporation under the trade name 556 Fluid. Trimethylsiloxyphenyl dimethicone is available from Wacker-Chemie under the trade name PDM-1000. Hexadecyl dimethicone, also known as liquid silicone wax, is available from Dow Corning as Fluid 2502 or from DeGussa Care & Surface Specialties under the trade name Abil Wax 9801 or 9814.

[0137] G.Sunscreen

[0138] It may also be desirable to include one or more sunscreens in the compositions of the present invention. Such sunscreens include chemical UVA or UVB sunscreens or physical sunscreens in particulate form. The addition of a sunscreen to a composition containing a whitening active ingredient will provide additional protection to the skin during daytime hours and promote the effectiveness of the whitening active ingredient on the skin. If present, the sunscreen may range from about 0.1% to 50%, preferably from about 0.5% to 40%, and more preferably from about 1% to 35%.

[0139] 1. UVA chemical sunscreen

[0140] If desired, the composition may include one or more UVA sunscreens. The term "UVA sunscreen" means a compound that blocks UV radiation in the wavelength range of about 320 nm to 400 nm. A preferred UVA sunscreen is a dibenzoylmethane compound of the formula:

[0141]

[0142] Where R1 is H, OR and NRR, where each R is independently H, C 1-20 Straight or branched alkyl; R2 is H or OH; and R3 is H, C 1-20 Straight chain or branched chain alkyl.

[0143] Preferred are those wherein R1 is OR, wherein R is C 1-20 Straight or branched alkyl, preferably methyl; R2 is H; and R3 is C 1-20 A straight chain or branched chain alkyl group, more preferably a butyl group.

[0144] Examples of suitable UVA sunscreen compounds of this general formula include 4-methyldibenzoylmethane, 2-methyldibenzoylmethane, 4-isopropyldibenzoylmethane, 4-tert-butyldibenzoylmethane, 2,4-dimethyldibenzoylmethane, 2,5-dimethyldibenzoylmethane, 4,4'-diisopropylbenzoylmethane, 4-tert-butyl-4'-methoxydibenzoylmethane, 4,4'-diisopropylbenzoylmethane, 2-methyl-5-isopropyl-4'-methoxydibenzoylmethane, 2-methyl-5-tert-butyl-4'-methoxydibenzoylmethane, and the like. Particularly preferred is 4-tert-butyl-4'-methoxydibenzoylmethane, also known as avobenzone. Avobenzone is available under the trademark 1789 is commercially available from Givaudan-Roure and under the trade name 9020 was commercially available from Merck & Co.

[0145] Other types of UVA sunscreens include dicamphorsulfonic acid derivatives such as ecamsule, sold under the trade name A sunscreen agent sold is terephthalylidene dicamphor sulfonic acid, having the formula:

[0146]

[0147] The composition may contain about 0.001%-20%, preferably 0.005%-5%, more preferably about 0.005%-3% by weight of the composition of a UVA sunscreen. In a preferred embodiment of the present invention, the UVA sunscreen is avobenzone and is present in an amount of no greater than about 3% by weight of the total composition.

[0148] 2. UVB chemical sunscreen

[0149] The term "UVB sunscreen" means a compound that blocks UV radiation in the wavelength range of about 290 nm to 320 nm. There are a variety of UVB chemical sunscreens, including α-cyano-β,β-diphenylacrylate, as described in U.S. Pat. No. 3,215,724, which is hereby incorporated by reference in its entirety. A specific example of an α-cyano-β,β-diphenylacrylate is octocrylene, which is 2-ethylhexyl 2-cyano-3,3-diphenylacrylate. In some cases, the composition may contain no more than about 10% octocrylene by weight of the total composition. A suitable amount is in the range of about 0.001% to 10% by weight. Octocrylene is available under the trade name N-539 was purchased from BASF.

[0150] Other suitable sunscreens include benzylidene camphor derivatives, such as those described in U.S. Pat. No. 3,781,417, which is hereby incorporated by reference in its entirety. Such benzylidene camphor derivatives have the general formula:

[0151]

[0152] wherein R is p-tolyl or styryl, preferably styryl. Particularly preferred is 4-methylbenzylidene camphor, a fat-soluble UVB sunscreen compound sold under the trade name Eusolex 6300 by Merck.

[0153] Also suitable are cinnamate derivatives having the general formula:

[0154]

[0155] Where R and R1 are each independently C 1-20 Straight or branched alkyl. Preferably, R is methyl and R1 is a branched C 1-10, preferably C8 alkyl. The preferred compound is ethylhexyl methoxycinnamate, also known as orcinol ester or octyl methoxycinnamate. This compound is available under the trade name MCX is available from Givaudan Corporation or under the trade name MC 80 was purchased from BASF.

[0156] Also suitable are mono-, di- and triethanolamine derivatives of such methoxycinnamates, including diethanolamine methoxycinnamate. Cinoxate, aromatic ether derivatives of the above compounds are also acceptable. If present, cinoxate should be found in no more than about 3% by weight of the total composition.

[0157] Various benzophenone derivatives having the general formula are also suitable as UVB screening agents:

[0158]

[0159] Wherein R to R9 are each independently H, OH, NaO3S, SO3H, SO3Na, Cl, R″, OR″, wherein R″ is C 1-20 Straight or branched alkyl. Examples of such compounds include benzophenone 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12. Particularly preferred benzophenone derivatives are benzophenone 3 (also known as oxybenzophenone), benzophenone 4 (also known as sulfoisobenzophenone), benzophenone 5 (sulfoisobenzophenone sodium), etc. Most preferred is benzophenone 3.

[0160] Also suitable are certain menthyl salicylate derivatives having the general formula:

[0161]

[0162] wherein R1, R2, R3 and R4 are each independently H, OH, NH2 or C 1-20 Straight or branched alkyl. Particularly preferred are those where R1, R2 and R3 are methyl and R4 is hydroxy or NH2, the compound having the name homomenthyl salicylate (also known as homosalate) or aminobenzoic acid amine. Homosalate can be obtained under the trademark HMS is commercially available from Merck, and aminobenzoic acid amine is available under the trademark Commercially available from Haarmann & Reimer. Homosalate, if present, should be found at no more than about 15% by weight of the total composition.

[0163] Various aminobenzoic acid derivatives are suitable UVB absorbers, including those having the general formula:

[0164]

[0165] Wherein R1, R2 and R3 are each independently H, C 1-20 Straight or branched alkyl, which may be substituted by one or more hydroxyl groups. Particularly preferred are those in which R1 is H or C 1-8 A straight chain or branched alkyl group, and R2 and R3 are H or C 1-8 Straight or branched chain alkyl. Particularly preferred are PABA, ethylhexyl dimethyl PABA (Padimalate O), ethyl dihydroxypropyl PABA, and the like. Padimalate O, if present, should be found in no more than about 8% by weight of the total composition.

[0166] Salicylate derivatives are also acceptable UVB absorbers. Such compounds have the general formula: wherein R is a straight or branched alkyl group, including derivatives of the above compounds formed from mono-, di- or triethanolamine. Particularly preferred are octyl salicylate, TEA-salicylate, DEA-salicylate and mixtures thereof.

[0167] Generally, UVB chemical sunscreens may be present in an amount ranging from about 0.001-45%, preferably 0.005-40%, more preferably about 0.01-35% by weight of the total composition.

[0168] If desired, the compositions of the present invention can be formulated to have a specific Sun Protection Factor (SPF) value of from about 1 to 50, preferably from about 2 to 45, and most preferably from about 5 to 30. The calculation of SPF values ​​is well known in the art.

[0169] H. Vitamins and Antioxidants

[0170] It may be desirable to incorporate one or more vitamins or antioxidants into the compositions of the present invention. If present, the suggested range is from about 0.001% to 20%, preferably from about 0.005% to 15%, more preferably from about 0.010% to 10%. Preferably, such vitamins, vitamin derivatives and / or antioxidants may be used to scavenge free radicals in the form of singlet oxygen. Such vitamins may include tocopherol or derivatives thereof, such as tocopherol acetate, tocopherol ferulate; ascorbic acid or derivatives thereof, such as ascorbyl palmitate, magnesium ascorbyl phosphate; vitamin A or derivatives thereof, such as retinyl palmitate; or vitamins D, K, B or derivatives thereof.

[0171] While not wishing to be bound by theory, it is believed that the delivery of Roselle extract and betaine compounds can reduce stress-induced cellular damage and counteract signs of stressor-induced epidermal osmotic imbalance, such as the appearance of fine lines and wrinkles, wilting, thinning, dryness, sagging, a dull appearance or heterogeneous surface of the skin.

[0172] The present invention therefore also relates to a non-therapeutic cosmetic treatment method for combating the signs of epidermal osmotic disturbances induced by stressors, such as the appearance of fine lines and wrinkles, withering, thinning, dryness, sagging, dull appearance or heterogeneous surface of the skin, which method comprises topically applying a composition as defined above to a keratinous substance, such as the skin. The term "stressor"

[0173] In one embodiment, the composition of the present invention can be topically applied to the neck, face, collar, back, hands or body parts in an effective amount such that the combination of the Roselle extract and the betaine compound can provide synergistic protective properties against osmotic stress.

[0174] The present invention also provides the use of roselle extract and betaine compound in preparing a medicine for treating signs of skin dehydration.

[0175] The present invention will be further described in conjunction with the following examples, which are set forth for purposes of illustration only.

[0176] Example

[0177] A. In vitro testing

[0178] 1. Preparation of active substances

[0179] 1.2 g of betaine (RDS 51-6709) was dissolved in 100 ml of water under magnetic stirring to completely dissolve (stock concentration 1.2%). 0.5 g of roselle extract (roselle extract, Lucas Meyer Cosmetics Company) was dissolved in 10 mL of water to achieve a 5% stock solution. The solution was then filtered with a 0.22 um filter to maintain sterility.

[0180] 2. Cell Culture

[0181] Normal human epidermal keratinocytes (NHEK, FC-0007) purchased from Lifeline cell technology were cultured in keratinocyte culture medium (DermaLife K keratinocyte culture medium complete kit, LL-0007, Lifeline Cell Technology) supplemented with growth factors and 1% penicillin / streptomycin (Thermo Fischer, Waltham, MA, USA) at 37°C, 95% humidity and 5% CO2. Cells were passaged when they reached 80% confluence.

[0182] 3. Cell culture medium components :

[0183]

[0184] 4. Establishment of Hyperosmotic Stress Model

[0185] NHEKs were plated in 96-well plates at a density of 4,000 / well. After 24 hours of incubation, cells will have reached approximately 80% confluence. 4.38 mg / mL NaCL was added to the medium to achieve an osmotic pressure of 450, ~300 mOsm above baseline.

[0186] 5. Cell Treatment

[0187] On day 1, NHEK were seeded with culture medium (DermaLife K Keratinocyte Culture Medium Complete Kit) at 3,000 cells / well in 96-well plates. After 24 hours of adhesion, a 2-active substance combination experiment was performed in vitro. 21 data points were used for dose and effect, including 4 concentrations of betaine, 7 concentrations of roselle extract and their combinations as follows (Table 1). Cells were treated with the combination of these active substances for 48 hours (diluted separately in cell culture medium and then mixed together to treat cells). The cells were then washed twice with Dulbecco's phosphate-buffered saline (DPBS) and then incubated in saline containing 10% alamarBlue. TM Cell viability reagent (Thermo Fisher, Waltham, MA, USA) was incubated for 120 minutes. The fluorescence of the incubated plates was measured at Ex 530nm / Em 615nm using a Perkin Elmer plate reader (VICTOR Nivo). These values ​​were recorded as RFU values.

[0188] 6. Cell protection rate

[0189] The protective effect can be determined by the cell survival rate (%) and cell protection rate (%) as follows.

[0190]

[0191] Cell protection rate (%) = (cell survival rate under 450mOSM-untreated cell survival rate under 450mOSM) / (untreated cell survival rate under 100-450mOSM)*100%

[0192] 7. Combination Index (CI)

[0193] According to the theory proposed by Chou and Talalay (TING-CHAO CHOU). Theoretical basis, experimental design and computer simulation of synergy and antagonism in drug combination studies. Pharmacol Rev58: 621-681, 2006), the level of synergy can usually be measured and quantified by the drug combination index (CI, a quantitative measure of the drug combination effect) from experimental dose response data. The concentration of each compound, the protection rate of each compound or the combined data of the two compounds are input into a computer for automatic analysis using CalcuSyn software. The combination index can be used to classify drug interactions as synergistic, additive or antagonistic, as shown below.

[0194] CI<1 synergistic effect

[0195] CI=1Additive

[0196] CI>1 antagonism

[0197] 8. Combination index: effect of betaine and roselle extract concentrations, combined concentration ratio and effect level.

[0198] The experiments were conducted at four levels of betaine and seven levels of roselle extract. The combination ratio indicates the mass concentration ratio of betaine to roselle extract. The synergy values ​​were classified based on the calculated combination index.

[0199] Table 1: NHEK treated with different concentrations of betaine and roselle

[0200]

[0201] B. Formulation Examples

[0202] The composition of the present invention containing the roselle extract and the betaine compound was prepared as follows.

[0203]

[0204]

[0205] The composition is prepared by thoroughly mixing these ingredients according to conventional methods.

[0206] While the present invention has been described in conjunction with the preferred embodiments, it is not intended to limit the scope of the invention to the specific forms set forth, but on the contrary, the invention is intended to cover such alternatives, modifications and equivalents as may be included within the spirit and scope of the invention as defined by the appended claims.

Claims

1. A composition, in particular a cosmetic and / or dermatological composition for topical application, comprising a Roselle extract and at least one betaine compound selected from the group consisting of betaine, its salts and analogs thereof.

2. The composition of claim 1, wherein the betaine compound is glycine betaine.

3. The composition according to claim 1 or 2, wherein the Roselle extract is derived from the fruit of the Roselle.

4. The composition according to any one of claims 1 to 3, wherein the Roselle extract is extracted by an aqueous extraction method.

5. The composition according to any one of claims 1 to 4, wherein the betaine compound and the roselle extract are present in a weight ratio of 3:1 to 3:10, preferably 3:1 to 6:10, and more preferably 9:5 to 9:

10.

6. The composition according to any one of claims 1 to 5, wherein the betaine compound is present in an amount of 0.01 to 0.2 wt. %, preferably 0.03 to 0.1 wt. %, relative to the total weight of the composition.

7. The composition according to any one of claims 1 to 6, wherein the Roselle extract is present in an amount of 0.01 to 0.1 wt%, preferably 0.02 to 0.1 wt%, and more preferably 0.05 to 0.1 wt%, relative to the total weight of the composition.

8. A method of non-therapeutic cosmetic treatment comprising topically applying a composition according to any one of claims 1 to 7 to a keratin material such as the skin.

9. The method according to claim 8, for combating signs of stress factor-induced epidermal osmotic disturbances, such as the appearance of fine lines and wrinkles, withering, thinning, dryness, sagging, dull appearance or heterogeneous surface of the skin.

10. The method according to claim 8 or 9, wherein the stress factor is UV radiation, chemical and / or osmotic stress.

11. Cosmetic use of a composition according to any one of claims 1 to 7 for caring for, protecting and / or making up the skin of the body or face, or for caring for the hair.

12. Use according to claim 11, for combating signs of stress factor-induced epidermal osmotic imbalance, such as the appearance of fine lines and wrinkles, withering, thinning, dryness, sagging, dull appearance or heterogeneous surface of the skin.

13. Use according to claim 11 or 12, wherein the stress factor is UV radiation, chemical and / or osmotic stress.